Form D Explorer

King Therapeutics LLC research brief

CIK 2088073

Generated Nov. 18, 2026, 2:46 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: PHOENIX Arizona. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

Reviewed offering links

Citation: Form D Explorer, “King Therapeutics LLC research brief,” CIK 2088073, retrieved Nov. 18, 2026, 2:46 a.m.. Cite the specific accessions used. No amounts have been summed.